EDC	endocrine disrupting compound
HPT	hypothalamus-pituitary-thyroid axis
TH	thyroid hormone
LC50	half maximal lethal concentration
EC50	half maximal effective concentration
LOEC	lowest observed effect concentration
NOEC	no observed effect concentration
ER	estrogen receptor
AR	androgen receptor
FI	fold induction
BPA	bisphenol A
pEDC	potential endocrine disrupting compound
DES	Diethylstilbestrol
END	Endosulfan
E2	17β-estradiol
FUL	Fulvestrant
HEX	Hexaconazole
MMI	Methimazole
17-αMT	17α-methyltestosterone
NAN	Nandrolone
NIL	Nilutamide
TES	Testosterone
T3	3,3′,5-triiodo-L-thyronine
VIN	Vinclozolin
DMSO	dimethyl sulfoxide
E3	control media